陈宏达, 郑荣寿, 王乐, 等. 2019年中国肿瘤流行病学研究进展[J]. 中华疾病控制杂志, 2020, 24(4): 373-379. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202004002.htm

孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901001.htm

王静雷, 杨一兵, 耿云霞, 等. 1990-2017年中国胃癌发病、患病及死亡状况趋势分析[J]. 中国慢性病预防与控制, 2020, 28(5): 321-325. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXB202005001.htm

Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention[J]. Cancer Res, 1992, 52(24): 6735-6740.

Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach(MAPS Ⅱ): European Society of Gastrointestinal Endoscopy(ESGE), European Helicobacter and Microbiota Study Group(EHMSG), European Society of Pathology(ESP), and Sociedade Portuguesa de Endoscopia Digestiva(SPED)guideline update 2019[J]. Endoscopy, 2019, 51(4): 365-388. doi: 10.1055/a-0859-1883

国家消化系疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化病学分会幽门螺杆菌学组, 等. 中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J]. 中华消化杂志, 2020, 40(11): 731-741. doi: 10.3760/cma.j.cn311367-20200915-00554

中华医学会消化病学分会. 中国慢性胃炎共识意见(2017年, 上海)[J]. 胃肠病学, 2017, 22(11): 670-687. doi: 10.3969/j.issn.1008-7125.2017.11.007

北京医学会消化内镜学分会. 胃低级别上皮内瘤变规范化诊治专家共识(2019)[J]. 中华胃肠内镜电子杂志, 2019, 6(2): 49-55. doi: 10.3877/cma.j.issn.2095-7157.2019.02.001

中华中医药学会脾胃病分会, 中国医师协会中西医结合医师分会消化病学专业委员会. 胃黏膜定标活检技术临床应用共识(2018)[J]. 中国中西医结合杂志, 2018, 38(12): 1496-1500. doi: 10.7661/j.cjim.20181017.310

中华中医药学会脾胃病分会, 张声生, 唐旭东. 慢性胃炎中医诊疗专家共识意见(2017)[J]. 中华中医药杂志, 2017, 32(7): 3060-3064. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201707063.htm

Nagayo T. Histological diagnosis of biopsied gastric mucosae with special reference to that of borderline lesion[J]. Gann Monogr, 1971, 11: 245-256.

Serck-Hanssen A. Precancerous lesions of the stomach[J]. Scand J Gastroenterol Suppl, 1979, 54: 104-105.

Hamilton SR, Aaltonen LA. World Health Organization Classification of TumoursPathology and genetics o ftumours of digestive system[M]. Lyon: IARC Press, 2000.

宁浩勇, 译. HO(2010)消化系统肿瘤组织学分类[J]. 诊断病理学杂志, 2011, 18(1): 77-79.

WHO Classification of Tumours Editorial Board. WHO classification of tumours of digestive system[M]. Lyon: IARC Press, 2019.

Du Y, Bai Y, Xie P, et al. Chronic gastritis in China: a national multi-center survey[J]. BMC Gastroenterol, 2014, 14: 21. doi: 10.1186/1471-230X-14-21

张慧, 薛艳, 周丽雅, 等. 北京某三级甲等医院35年间主要上消化道疾病及幽门螺杆菌感染的演变[J]. 中华内科杂志, 2016, 55(6): 440-444. doi: 10.3760/cma.j.issn.0578-1426.2016.06.008

Sipponen P, Maaroos HI. Chronic gastritis[J]. Scand J Gastroenterolo, 2015, 50(6): 657-667. doi: 10.3109/00365521.2015.1019918

Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer[J]. J Cancer Prev, 2015, 20(1): 25-40. doi: 10.15430/JCP.2015.20.1.25

Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(6): 1083-1094. doi: 10.1158/1055-9965.EPI-05-0931

Adamu MA, Weck MN, Gao L, et al. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies[J]. Eur J Epidemiol, 2010, 25(7): 439-448. doi: 10.1007/s10654-010-9482-0

Gao L, Weck MN, Raum E, et al. Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany[J]. Int J Epidemiol, 2010, 39(1): 129-134. doi: 10.1093/ije/dyp250

Yeh LY, Raj M, Hassan S, et al. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori[J]. Indian J Gastroenterol, 2009, 28(2): 49-52. doi: 10.1007/s12664-009-0017-0

Nguyen TL, Uchida T, Tsukamoto Y, et al. Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study[J]. BMC Gastroenterol, 2010, 10: 114. doi: 10.1186/1471-230X-10-114

沈洪. 慢性萎缩性胃炎及其癌前病变治疗之管见[J]. 江苏中医药, 2007, 39(8): 6-7. doi: 10.3969/j.issn.1672-397X.2007.08.006

史锁芳, 陆为民. 单兆伟教授论治慢性萎缩性胃炎癌前病变的经验[J]. 中医教育, 1998, 17(4): 44-46. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJI199804019.htm

胡玲, 马剑颖. 劳绍贤教授辨治胃癌癌前疾病经验介绍[J]. 新中医, 2006, 38(5): 7-9. doi: 10.3969/j.issn.0256-7415.2006.05.004

苏泽琦, 张文君, 张雨珊, 等. 慢性胃炎恶性转化过程证候、证素演变规律[J]. 现代中医临床, 2017, 24(6): 9-14. doi: 10.3969/j.issn.2095-6606.2017.06.003

苏泽琦, 李培彩, 郭强, 等. 慢性胃炎中医证候演变规律研究[J]. 北京中医药大学学报, 2015, 38(11): 762-766, 771. doi: 10.3969/j.issn.1006-2157.2015.11.010

程若东, 崔一鸣, 陈璐, 等. 基于logistic回归模型的慢性萎缩性胃炎癌前病变中医证型规律研究[J]. 中华中医药杂志, 2018, 33(8): 3623-3626. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201808109.htm

晁俊, 甄晓敏, 刘绍能. 慢性萎缩性胃炎中医证候演变规律研究[J]. 北京中医药, 2019, 38(1): 48-50. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201901015.htm

Yao K, Nagahama T, Matsui T, et al. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection[J]. Dig Endosc, 2013, 25(Suppl 1): 44-54.

Yao K, Uedo N, Kamada T, et al. Guidelines for endoscopic diagnosis of early gastric cancer[J]. Dig Endosc, 2020, 32(5): 663-698. doi: 10.1111/den.13684

Bertoni G, Gumina C, Conigliaro R, et al. Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy[J]. Endoscopy, 1992, 24(4): 268-270. doi: 10.1055/s-2007-1010479

Lee GJ, Park SJ, Kim SJ, et al. Effectiveness of Premedication with Pronase for Visualization of the Mucosa during Endoscopy: A Randomized, Controlled Trial[J]. Clin Endosc, 2012, 45(2): 161-164. doi: 10.5946/ce.2012.45.2.161

Lee SY, Han HS, Cha JM, et al. Endoscopic flushing with pronase improves the quantity and quality of gastric biopsy: a prospective study[J]. Endoscopy, 2014, 46(9): 747-753. doi: 10.1055/s-0034-1365811

Kim GH, Cho YK, Cha JM, et al. Effect of pronase as mucolytic agent on imaging quality of magnifying endoscopy[J]. World J Gastroenterol, 2015, 21(8): 2483-2489. doi: 10.3748/wjg.v21.i8.2483

陈新波, 初国艳, 卢朝辉, 等. 二甲硅油散和糜蛋白酶联合应用在胃镜检查中的价值[J]. 重庆医学, 2018, 47(20): 2744-2746. doi: 10.3969/j.issn.1671-8348.2018.20.028

Liu X, Guan CT, Xue LY, et al. Effect of premedication on lesion detection rate and visualization of the mucosa during upper gastrointestinal endoscopy: a multicenter large sample randomized controlled double-blind study[J]. Surg Endosc, 2018, 32(8): 3548-3556. doi: 10.1007/s00464-018-6077-4

Yao K. The endoscopic diagnosis of early gastric cancer[J]. Ann Gastroenterol, 2013, 26(1): 11-22.

Hiki N, Kurosaka H, Tatsutomi Y, et al. Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial[J]. Gastrointest Endosc, 2003, 57(4): 475-482. doi: 10.1067/mge.2003.156

Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation[J]. Gastroenterology, 2007, 133(2): 675-701. doi: 10.1053/j.gastro.2007.06.002

Obara K, Haruma K, Irisawa A, et al. Guidelines for sedation in gastroenterological endoscopy[J]. Dig Endosc, 2015, 27(4): 435-449. doi: 10.1111/den.12464

Probert CS, Jayanthi V, Quinn J, et al. Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract[J]. Endoscopy, 1991, 23(4): 218-219. doi: 10.1055/s-2007-1010661

李鹏, 冀明, 张澍田. 无痛消化内镜操作共识[J]. 中国实用内科杂志, 2010, 30(7): 605-607. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201007011.htm

Panteris V, Nikolopoulou S, Lountou A, et al. Diagnostic capabilities of high-definition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data[J]. Eur J Gastroenterol Hepatol, 2014, 26(6): 594-601. doi: 10.1097/MEG.0000000000000097

Pimentel-Nunes P, Libânio D, Lage J, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions[J]. Endoscopy, 2016, 48(8): 723-730. doi: 10.1055/s-0042-108435

Zhao Z, Yin Z, Wang S, et al. Meta-analysis: The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions[J]. J Gastroenterol Hepatol, 2016, 31(9): 1539-1545. doi: 10.1111/jgh.13313

Kikuste I, Marques-Pereira R, Monteiro-Soares M, et al. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies[J]. Scand J Gastroenterol, 2013, 48(10): 1108-1117. doi: 10.3109/00365521.2013.825315

Ang TL, Pittayanon R, Lau JY, et al. A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions[J]. Eur J Gastroenterol Hepatol, 2015, 27(12): 1473-1478. doi: 10.1097/MEG.0000000000000478

Dutta AK, Sajith KG, Pulimood AB, et al. Narrow band imaging versus white light gastroscopy in detecting potentially premalignant gastric lesions: a randomized prospective crossover study[J]. Indian J Gastroenterol, 2013, 32(1): 37-42. doi: 10.1007/s12664-012-0246-5

李发旺, 王兴胜, 尹雯. 电子染色技术联合靛胭脂染色在早期胃癌及癌前病变诊断中的价值[J]. 甘肃医药, 2017, 36(1): 44-46. https://www.cnki.com.cn/Article/CJFDTOTAL-GSYY201701019.htm

张丽媛. NBI技术联合醋酸及亚甲蓝染色在早期胃癌及癌前病变应用的分析[J]. 福建医药杂志, 2018, 40(5): 38-40. https://www.cnki.com.cn/Article/CJFDTOTAL-FJYY201805017.htm

张阳, 张蕾, 梁迎迎. 内镜下醋酸染色联合窄带光成像诊断早期胃癌及癌前病变的价值研究[J]. 临床医学, 2019, 39(12): 49-51. https://www.cnki.com.cn/Article/CJFDTOTAL-EBED201912022.htm

Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut, 2015, 64(9): 1353-1367. doi: 10.1136/gutjnl-2015-309252

Banks M, Graham D, Jansen M, et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma[J]. Gut, 2019, 68(9): 1545-1575. doi: 10.1136/gutjnl-2018-318126

中华医学会消化内镜学分会病理学协作组. 中国消化内镜活组织检查与病理学检查规范专家共识(草案)[J]. 中华消化杂志, 2014, 34(9): 577-581. doi: 10.3760/cma.j.issn.0254-1432.2014.09.001

中华医学会病理分会消化病理学组筹备组. 慢性胃炎及上皮性肿瘤胃黏膜活检病理诊断共识[J]. 中华病理学杂志, 2017, 46(5): 289-293. doi: 10.3760/cma.j.issn.0529-5807.2017.05.001

Lash JG, Genta RM. Adherence to the Sydney System guidelines increases the detection of Helicobacter gastritis and intestinal metaplasia in 400738 sets of gastric biopsies[J]. Aliment Pharmacol Ther, 2013, 38(4): 424-31. doi: 10.1111/apt.12383

Kwack WG, Ho WJ, Kim JH, et al. Understanding the diagnostic yield of current endoscopic biopsy for gastric neoplasm: A prospective single-center analysis based on tumor characteristics stratified by biopsy number and site[J]. Medicine(Baltimore), 2016, 95(30): e4196.

Januszewicz W, Wieszczy P, Bialek A, et al. Endoscopist biopsy rate as a quality indicator for outpatient gastroscopy: a multicenter cohort study with validation[J]. Gastrointest Endosc, 2019, 89(6): 1141-1149. doi: 10.1016/j.gie.2019.01.008

Sun L, Si J, Chen S, et al. The establishment and clinical appliance of technique of mucosa marking targeting biopsy[J]. Hepatogastroenterology, 2009, 56(89): 59-62.

孙蕾民, 姒健敏, 樊宇靖. 一步法内镜标定活检的实验研究[J]. 中华消化杂志, 2006, 26(7): 488-489. doi: 10.3760/j.issn:0254-1432.2006.07.019

刘海燕, 陈永灿, 潘庆, 等. 运用定标活检技术评价半夏泻心汤治疗慢性萎缩性胃炎的疗效[J]. 中华中医药学刊, 2014, 32(4): 804-807. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201404033.htm

中华医学会消化病学分会, 房静远, 刘文忠, 等. 中国慢性胃炎共识意见(2012年, 上海)[J]. 中华消化杂志, 2013, 33(1): 5-16. doi: 10.3760/cma.j.issn.0254-1432.2013.01.003

吴益群, 林琪, 孙校男, 等. 定标活检术在胃黏膜病变治疗随访中的价值研究[J]. 中华消化内镜杂志, 2016, 33(8): 551-553. doi: 10.3760/cma.j.issn.1007-5232.2016.08.014

Kim CG. Tissue acquisition in gastric epithelial tumor prior to endoscopic resection[J]. Clin Endosc, 2013, 46(5): 436-440. doi: 10.5946/ce.2013.46.5.436

Graham DY, Schwartz JT, Cain GD, et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma[J]. Gastroenterology, 1982, 82(2): 228-231. doi: 10.1016/0016-5085(82)90009-9

中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜学专业委员会. 中国早期胃癌筛查及内镜诊治共识意见(2014年, 长沙)[J]. 中华消化内镜杂志, 2014, 31(7): 361-377. doi: 10.3760/cma.j.issn.1007-5232.2014.07.001

Nishitani M, Yoshida N, Tsuji S, et al. Optimal number of endoscopic biopsies for diagnosis of early gastric cancer[J]. Endosc Int Open, 2019, 7(12): E1683-E1690. doi: 10.1055/a-1007-1730

Yao K, Doyama H, Gotoda T, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study[J]. Gastric Cancer, 2014, 17(4): 669-679. doi: 10.1007/s10120-013-0332-0

Chiu P, Uedo N, Singh R, et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia[J]. Gut, 2019, 68(2): 186-197. doi: 10.1136/gutjnl-2018-317111

小山恒男. 早期胃癌内镜诊断的方法与策略[M]. 沈阳: 辽宁科学技术出版社, 2017: 29-32.

Filipe MI, Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia[J]. Int J Cancer, 1994, 57(3): 324-329. doi: 10.1002/ijc.2910570306

Conchillo JM, Houben G, de Bruïne A, et al. Is type Ⅲ intestinal metaplasia an obligatory precancerous lesion in intestinal-type gastric carcinoma?[J]. Eur J Cancer Prev, 2001, 10(4): 307-312. doi: 10.1097/00008469-200108000-00003

Piazuelo MB, Camargo MC, Mera RM, et al. Gastric intestinal metaplasia type Ⅲ and prospective risk of gastric cancer in colombia[J]. Gastroenterology, 2017, 152: S473.

Shah SC, Gawron AJ, Mustafa RA, et al. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice[J]. Gastroenterology, 2020, 158(3): 745-750. doi: 10.1053/j.gastro.2019.12.004

Silva E, Teixeira A, David L, et al. Mucins as key molecules for the classification of intestinal metaplasia of the stomach[J]. Virchows Arch, 2002, 440(3): 311-317. doi: 10.1007/s004280100531

Duan X, Lian H, Li J, et al. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia[J]. Diagn Pathol, 2019, 14(1): 61. doi: 10.1186/s13000-019-0838-9

Dong B, Xie YQ, Chen K, et al. Differences in biological features of gastric dysplasia, indefinite dysplasia, reactive hyperplasia and discriminant analysis of these lesions[J]. World J Gastroenterol, 2005, 11(23): 3595-3600. doi: 10.3748/wjg.v11.i23.3595

Baldus SE, Mönig SP, Arkenau V, et al. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma[J]. Ann Surg Oncol, 2002, 9(9): 887-893. doi: 10.1007/BF02557526

Simone A, Casadei A, De Vergori E, et al. Rescue endoscopy to identify site of gastric dysplasia or carcinoma found at random biopsies[J]. Dig Liver Dis, 2011, 43(9): 721-725. doi: 10.1016/j.dld.2011.04.007

de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands[J]. Gastroenterology, 2008, 134(4): 945-952. doi: 10.1053/j.gastro.2008.01.071

Akbari M, Kardeh B, Tabrizi R, et al. Incidence Rate of Gastric Cancer Adenocarcinoma in Patients With Gastric Dysplasia: A Systematic Review and Meta-Analysis[J]. J Clin Gastroenterol, 2019, 53(10): 703-710. doi: 10.1097/MCG.0000000000001257

Lim H, Jung HY, Park YS, et al. Discrepancy between endoscopic forceps biopsy and endoscopic resection in gastric epithelial neoplasia[J]. Surg Endosc, 2014, 28(4): 1256-1262. doi: 10.1007/s00464-013-3316-6

Zhao G, Xue M, Hu Y, et al. How Commonly Is the Diagnosis of Gastric Low Grade Dysplasia Upgraded following Endoscopic Resection? A Meta-Analysis[J]. PLoS One, 2015, 10(7): e0132699. doi: 10.1371/journal.pone.0132699

吴蓓, 令狐恩强, 杨杰, 等. 胃黏膜低级别上皮内瘤变的临床病理及转归[J]. 军医进修学院学报, 2011, 32(6): 598-600. https://www.cnki.com.cn/Article/CJFDTOTAL-JYJX201106024.htm

Goo JJ, Choi CW, Kang DH, et al. Risk factors associated with diagnostic discrepancy of gastric indefinite neoplasia: Who need en bloc resection?[J]. Surg Endosc, 2015, 29(12): 3761-3767. doi: 10.1007/s00464-015-4151-8

Raftopoulos SC, Kumarasinghe P, de Boer B, et al. Gastric intraepithelial neoplasia in a Western population[J]. Eur J Gastroenterol Hepatol, 2012, 24(1): 48-54. doi: 10.1097/MEG.0b013e32834dc1bb

Fassan M, Pizzi M, Farinati F, et al. Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy[J]. Am J Clin Pathol, 2012, 137(5): 727-732. doi: 10.1309/AJCPEU41HTGXSJDQ

Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia[J]. Gastroenterology, 1994, 107(5): 1288-1296. doi: 10.1016/0016-5085(94)90529-0

Rugge M, Leandro G, Farinati F, et al. Gastric epithelial dysplasia. How clinicopathologic background relates to management[J]. Cancer, 1995, 76(3): 376-382. doi: 10.1002/1097-0142(19950801)76:3<376::AID-CNCR2820760305>3.0.CO;2-A

Kapadia CR. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective[J]. J Clin Gastroenterol, 2003, 36(5 Suppl): S29-S36.

Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification[J]. Acta Pathol Microbiol Scand, 1965, 64: 31-49. doi: 10.1111/apm.1965.64.1.31

Fukao A, Hisamichi S, Ohsato N, et al. Correlation between the prevalence of gastritis and gastric cancer in Japan[J]. Cancer Causes Control, 1993, 4(1): 17-20. doi: 10.1007/BF00051709

Genta RM. Review article: Gastric atrophy and atrophic gastritis--nebulous concepts in search of a definition[J]. Aliment Pharmacol Ther, 1998, 12(Suppl 1): 17-23.

Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication[J]. Gastrointest Endosc, 2016, 84(4): 618-624. doi: 10.1016/j.gie.2016.03.791

Lahner E, Esposito G, Pilozzi E, et al. Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up[J]. Scand J Gastroenterol, 2015, 50(7): 856-865. doi: 10.3109/00365521.2015.1010570

Reddy KM, Chang JI, Shi JM, et al. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System[J]. Clin Gastroenterol Hepatol, 2016, 14(10): 1420-1425. doi: 10.1016/j.cgh.2016.05.045

Zhou Y, Li HY, Zhang JJ, et al. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer[J]. World J Gastroenterol, 2016, 22(13): 3670-3678. doi: 10.3748/wjg.v22.i13.3670

Kodama M, Murakami K, Okimoto T, et al. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer[J]. Scand J Gastroenterol, 2013, 48(11): 1249-1256. doi: 10.3109/00365521.2013.838994

Oliveira C, Pinheiro H, Figueiredo J, et al. Familial gastric cancer: genetic susceptibility, pathology, and implications for management[J]. Lancet Oncol, 2015, 16(2): E60-E70. doi: 10.1016/S1470-2045(14)71016-2

Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer[J]. Br J Cancer, 2010, 102(2): 237-242. doi: 10.1038/sj.bjc.6605380

Safaee A, Moghimi-Dehkordi B, Fatemi SR, et al. Family history of cancer and risk of gastric cancer in Iran[J]. Asian Pac J Cancer Prev, 2011, 12(11): 3117-3120.

Masuyama H, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk[J]. Digestion, 2015, 91(1): 30-36. doi: 10.1159/000368807

Kuipers EJ. Pernicious Anemia, Atrophic Gastritis, and the Risk of Cancer[J]. Clin Gastroenterol Hepatol, 2015, 13(13): 2290-2292. doi: 10.1016/j.cgh.2015.07.013

Murphy G, Dawsey SM, Engels EA, et al. Cancer Risk After Pernicious Anemia in the US Elderly Population[J]. Clin Gastroenterol Hepatol, 2015, 13(13): 2282-2289. doi: 10.1016/j.cgh.2015.05.040

Ye W, Nyrén O. Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia[J]. Gut, 2003, 52(7): 938-941. doi: 10.1136/gut.52.7.938

Vannella L, Lahner E, Osborn J, et al. Systematic review: gastric cancer incidence in pernicious anaemia[J]. Aliment Pharmacol Ther, 2013, 37(4): 375-382. doi: 10.1111/apt.12177

Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer. A population-based cohort study[J]. Cancer, 1993, 71(3): 745-750. doi: 10.1002/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1

Brinton LA, Gridley G, Hrubec Z, et al. Cancer risk following pernicious anaemia[J]. Br J Cancer, 1989, 59(5): 810-813. doi: 10.1038/bjc.1989.169

Sjöblom SM, Sipponen P, Järvinen H. Gastroscopic follow up of pernicious anaemia patients[J]. Gut, 1993, 34(1): 28-32. doi: 10.1136/gut.34.1.28

Armbrecht U, Stockbrügger RW, Rode J, et al. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients[J]. Gut, 1990, 31(10): 1105-1109. doi: 10.1136/gut.31.10.1105

Lahner E, Caruana P, D'Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done?[J], Gastrointest Endosc, 2001, 53(4): 443-448. doi: 10.1067/mge.2001.112189

Cai Q, Zhu C, Yuan Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study[J]. Gut, 2019, 68(9): 1576-1587. doi: 10.1136/gutjnl-2018-317556

Zagari RM, Rabitti S, Greenwood DC, et al. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis[J]. Aliment Pharmacol Ther, 2017, 46(7): 657-667. doi: 10.1111/apt.14248

Syrjanen K, A Panel of Serum Biomarkers(GastroPanel^®)in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis[J]. Anticancer Res, 2016, 36(10): 5133-5144. doi: 10.21873/anticanres.11083

Chen Z, Hong L, Liu L, et al. Monoclonal antibody MG7 as a screening tool for gastric cancer[J]. Hybridoma(Larchmt), 2010, 29(1): 27-30.

Zhang L, Ren J, Pan K, et al. Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening[J]. Int J Cancer, 2010, 126(2): 469-473. doi: 10.1002/ijc.24739

Guo DL, Dong M, Wang L, et al. Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori-associated gastric diseases[J]. World J Gastroenterol, 2002, 8(6): 1009-1013. doi: 10.3748/wjg.v8.i6.1009

Jiang J, Shen S, Dong N, et al. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases[J]. Cancer Med, 2018, 7(8): 4068-4076. doi: 10.1002/cam4.1615

杨振华, 孙波, 黄傲霜, 等. 慢性萎缩性胃炎中医证候的胃镜及病理特征分析研究[J]. 中国中西医结合消化杂志, 2021, 29(1): 58-61. doi: 10.3969/j.issn.1671-038X.2021.01.12

宋健, 袁敏惠, 刘争辉, 等. 基于血清胃蛋白酶原水平对于胃癌前病变高危证候类型的癌变风险相关性研究[J]. 时珍国医国药, 2020, 31(7): 1658-1660. doi: 10.3969/j.issn.1008-0805.2020.07.037

杨洋, 瞿先侯, 杨敏, 等. 慢性萎缩性胃炎患者中医证候分型与癌变风险的相关性[J]. 中医杂志, 2020, 61(4): 319-324. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202004013.htm

王萍, 史彬, 温艳东, 等. 胃癌前病变病证结合风险预测模型的构建研究[J]. 中国中西医结合杂志, 2018, 38(7): 773-778. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201807001.htm

Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori[J]. Mod Pathol, 1993, 6(3): 281-289.

Kawai T, Moriyasu F, Tsuchida A. Key Issues Associated with Helicobacter pylori Eradication[J]. Digestion, 2016, 93(1): 19-23. doi: 10.1159/000441667

Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study[J]. Gastroenterology, 2000, 119(1): 7. doi: 10.1053/gast.2000.8550

Gong EJ, Kim DH, Ahn JY, et al. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy[J]. Digestion, 2020, 101(3): 279-286. doi: 10.1159/000499424

Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer[J]. Int J Cancer, 2004, 109(1): 138-143. doi: 10.1002/ijc.11680

Du YQ, Tun S, Hao JY, et al. Gastro-protecting effect of gefarnate on chronic erosive gastritis with dyspeptic symptoms[J]. Chin Med J(Engl), 2012, 125(16): 2878-2884.

Yun CY, Kim N, Lee J, et al. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors[J]. Helicobacter, 2018, 23(6): e12542.

Mera RM, Bravo LE, Camargo MC, et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial[J]. Gut, 2018, 67(7): 1239-1246. doi: 10.1136/gutjnl-2016-311685

Rugge M, Meggio A, Pravadelli C, et al. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients[J]. Gut, 2019, 68(1): 11-17. doi: 10.1136/gutjnl-2017-314600

Yamada H, Ikegami M, Shimoda T, et al. Long-term follow-up study of gastric adenoma/dysplasia[J]. Endoscopy, 2004, 36(5): 390-396. doi: 10.1055/s-2004-814330

Kang DH, Choi CW, Kim HW, et al. Predictors of upstage diagnosis after endoscopic resection of gastric low-grade dysplasia[J]. Surg Endosc, 2018, 32(6): 2732-2738. doi: 10.1007/s00464-017-5971-5

Yang L, Jin P, Wang X, et al. Risk factors associated with histological upgrade of gastric low-grade dysplasia on pretreatment biopsy[J]. J Dig Dis, 2018, 19(10): 596-604. doi: 10.1111/1751-2980.12669

Min BH, Kim KM, Kim ER, et al. Endoscopic and histopathological characteristics suggesting the presence of gastric mucosal high grade neoplasia foci in cases initially diagnosed as gastric mucosal low grade neoplasia by forceps biopsy in Korea[J]. J Gastroenterol, 2011, 46(1): 17-24. doi: 10.1007/s00535-010-0289-2

Kurilovich S, Belkovets A, Reshetnikov O, et al. Stomach-specific Biomarkers(GastroPanel)Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia[J]. Anticancer Res, 2016, 36(1): 247-253.

Ryu DG, Choi CW, Kang DH, et al. Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia[J]. Medicine(Baltimore), 2018, 97(33): e11802.

Back MK, Moon HS, Kwon IS, et al. Analysis of factors associated with local recurrence after endoscopic resection of gastric epithelial dysplasia: a retrospective study[J]. BMC Gastroenterol, 2020, 20(1): 148. doi: 10.1186/s12876-020-01293-0

Kwon MJ, Kang HS, Kim HT, et al. Treatment for gastric 'indefinite for neoplasm/dysplasia' lesions based on predictive factors[J]. World J Gastroenterol, 2019, 25(4): 469-484. doi: 10.3748/wjg.v25.i4.469

Lee H, Kim H, Shin SK, et al. The diagnostic role of endoscopic submucosal dissection for gastric lesions with indefinite pathology[J]. Scand J Gastroenterol, 2012, 47(8-9): 1101-1107. doi: 10.3109/00365521.2012.704939

Yu CH, Jeon SW, Kim SK, et al. Endoscopic resection as a first therapy for gastric epithelial atypia: is it reasonable?[J]. Dig Dis Sci, 2014, 59(12): 3012-3120. doi: 10.1007/s10620-014-3249-5

北京市科委重大项目《早期胃癌治疗规范研究》专家组, 柴宁莉, 翟亚奇, 等. 早期胃癌内镜下规范化切除的专家共识意见(2018, 北京)[J]. 中华胃肠内镜电子杂志, 2018, 5(2): 49-60. doi: 10.3877/cma.j.issn.2095-7157.2018.02.001

袁经祥. 内镜下高频电凝电切术配合康复新液治疗胃肠息肉32例报告[J]. 中国医药指南, 2008, 6(15): 144-145. doi: 10.3969/j.issn.1671-8194.2008.15.097

文玉平, 彭凤英. 康复新液在上消化道息肉电切术后的应用效果观察[J]. 海南医学, 2012, 23(1): 70-71. doi: 10.3969/j.issn.1003-6350.2012.01.032

王宏光, 王莹, 郭庆梅. 康复新液联合泮托拉唑治疗胃黏膜切除术后相关溃疡120例[J]. 中国中西医结合消化杂志, 2013, 21(7): 382-383. doi: 10.3969/j.issn.1671-038X.2013.07.015

唐少波, 王美丽, 梁健, 等. 健胃愈疡片治疗胃癌前病变的疗效观察[J]. 现代中西医结合杂志, 2009, 18(30): 3678-3679. doi: 10.3969/j.issn.1008-8849.2009.30.010

王昌雄, 王巧明, 宋力伟, 等. 健胃愈疡片修复内镜治疗术后"医源性溃疡"[J]. 中国医学创新, 2015, 12(7): 22-24. doi: 10.3969/j.issn.1674-4985.2015.07.007

中华医学会消化病分会幽门螺杆菌和消化性溃疡学组, 全国幽门螺杆菌研究协作组. 第五次全国幽门螺旋杆菌感染处理共识报告[J]. 中国实用内科杂志, 2017, 37(6): 509-524.

夏中伟, 江淦达. 葛根芩连汤抗伤寒杆菌活性和体外配伍抗菌药的实验观察[J]. 实用中西医结合杂志, 1996, 9(7): 394-394.

李仝. 中医药防治细菌耐药性的研究概况[J]. 中国医药学报, 2001, 16(3): 29-32. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY200103007.htm

史继波. 中西医结合治疗幽门螺杆菌阳性患者疗效观察[J]. 现代中西医结合杂志, 2003, 12(7): 721-721. doi: 10.3969/j.issn.1008-8849.2003.07.038

华志民, 马忠琴, 童蓓丽, 等. 四联疗法联合中医药对幽门螺杆菌的补救治疗[J]. 中华中西医杂志, 2008, 9(2): 115-118. https://www.cnki.com.cn/Article/CJFDTOTAL-WCBX201208011.htm

申小惠, 崔闽鲁. 中西医治疗耐药幽门螺杆菌的研究进展[J]. 福建医药杂志, 2008, 30(4): 91-93. doi: 10.3969/j.issn.1002-2600.2008.04.052

王淼蕾, 刘俊宏, 毛兰芳, 等. 胃癌前病变诊治中西医研究进展[J]. 中医药临床杂志, 2020, 32(1): 171-174. https://www.cnki.com.cn/Article/CJFDTOTAL-AHLC202001045.htm

姜宁, 黄宣, 范一宏, 等. 中西医结合治疗胃癌前病变疗效的系统评价[J]. 中华中医药学刊, 2015, 33(1): 149-154. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201501049.htm

Lundell L, Miettinen P, Myrvold HE, et al. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group[J]. Gastroenterology, 1999, 117(2): 319-326. doi: 10.1053/gast.1999.0029900319

Eslami L, Nasseri-Moghaddam S. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?[J]. Arch Iran Med, 2013, 16(8): 449-458.

Song H, Zhu J, Lu D. Long-term proton pump inhibitor(PPI)use and the development of gastric pre-malignant lesions[J]. Cochrane Database Syst Rev, 2014, (12): CD010623.

Nasser SC, Slim M, Nassif JG, et al. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes[J]. World J Gastroenterol, 2015, 21(15): 4599-4606. doi: 10.3748/wjg.v21.i15.4599

Niikura R, Hayakawa Y, Hirata Y, et al. The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion[J]. Int J Mol Sci, 2019, 20(8): 1913. doi: 10.3390/ijms20081913

Seo SI, Park CH, You SC, et al. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea[J]. Gut, 2021, 70(11): 2066-2075. doi: 10.1136/gutjnl-2020-323845

Dias-Neto M, Pintalhao M, Ferreira M, et al. Salt intake and risk of gastric intestinal metaplasia: systematic review and meta-analysis[J]. Nutr Cancer, 2010, 62(2): 133-147. doi: 10.1080/01635580903305391

Park YM, Kim JH, Baik SJ, et al. Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: An individualized consideration of the risk factors[J]. Medicine(Baltimore), 2016, 95(44): e5351.

Song JH, Kim YS, Heo NJ, et al. High Salt Intake Is Associated with Atrophic Gastritis with Intestinal Metaplasia[J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(7): 1133-1138. doi: 10.1158/1055-9965.EPI-16-1024

Thapa S, Fischbach LA, Delongchamp R, et al. Association between Dietary Salt Intake and Progression in the Gastric Precancerous Process[J]. Cancers(Basel), 2019, 11(4): 467.

Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study[J]. Int J Cancer, 2006, 119(1): 196-201. doi: 10.1002/ijc.21822

柯丽, 张迪, 陈瑜, 等. 中国西北地区胃黏膜肠上皮化生危险因素调查[J]. 现代生物医学进展, 2016, 16(34): 6639-6643. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201634010.htm

Yu Y, Fang C, Peng C, et al. Risk factors for gastric intraepithelial neoplasia in Chinese adults: a case-control study[J]. Cancer Manag Res, 2018, 10: 2605-2613. doi: 10.2147/CMAR.S166472

Zhu H, Xu H. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans[J]. Am J Gastroenterol, 2020, 115(9): 1539.

Lahner E, Carabotti M, Esposito G, et al. Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms[J]. Eur J Gastroenterol Hepatol, 2018, 30(11): 1291-1296. doi: 10.1097/MEG.0000000000001246

You WC, Li JY, Zhang L, et al. Etiology and prevention of gastric cancer: a population study in a high risk area of China[J]. Chin J Dig Dis, 2005, 6(4): 149-154. doi: 10.1111/j.1443-9573.2005.00222.x

Xing J, Min L, Zhu S, et al. Factors associated with gastric adenocarcinoma and dysplasia in patients with chronic gastritis: a population-based study[J]. Chin J Cancer Res, 2017, 29(4): 341-350. doi: 10.21147/j.issn.1000-9604.2017.04.07

Kim K, Chang Y, Ahn J, et al. Smoking and Urinary Cotinine Levels Are Predictors of Increased Risk for Gastric Intestinal Metaplasia[J]. Cancer Res, 2019, 79(3): 676-684. doi: 10.1158/0008-5472.CAN-18-2268

Peleteiro B, Lunet N, Figueiredo C, et al. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(2): 322-326. doi: 10.1158/1055-9965.EPI-06-0885

Kato I, Vivas J, Plummer M, et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela[J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(3): 468-476.

Nakamura M, Haruma K, Kamada T, et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects[J]. Dig Dis Sci, 2002, 47(3): 675-681. doi: 10.1023/A:1017901110580

Nieminen AA, Kontto J, Puolakkainen P, et al. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis[J]. Scand J Gastroenterol, 2019, 54(2): 145-151. doi: 10.1080/00365521.2019.1566492

Nam JH, Choi IJ, Kook MC, et al. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population[J]. Helicobacter, 2014, 19(2): 81-89. doi: 10.1111/hel.12112

Sobala GM, Pignatelli B, Schorah CJ, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach[J]. Carcinogenesis, 1991, 12(2): 193-198. doi: 10.1093/carcin/12.2.193

Sobala GM, O'Connor HJ, Dewar EP, et al. Bile reflux and intestinal metaplasia in gastric mucosa[J]. J Clin Pathol, 1993, 46(3): 235-240. doi: 10.1136/jcp.46.3.235

Matsuhisa T, Arakawa T, Watanabe T, et al. Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: a multicenter study of 2283 cases[J]. Dig Endosc, 2013, 25(5): 519-525. doi: 10.1111/den.12030

Matsuhisa T, Tsukui T. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens[J]. J Clin Biochem Nutr, 2012, 50(3): 217-221. doi: 10.3164/jcbn.11-90

Dixon MF, Mapstone NP, Neville PM, et al. Bile reflux gastritis and intestinal metaplasia at the cardia[J]. Gut, 2002, 51(3): 351-355. doi: 10.1136/gut.51.3.351

Li D, Zhang J, Yao WZ, et al. The relationship between gastric cancer, its precancerous lesions and bile reflux: A retrospective study[J]. J Dig Dis, 2020, 21(4): 222-229. doi: 10.1111/1751-2980.12858

Zhang LY, Zhang J, Li D, et al. Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study[J]. J Dig Dis, 2021, 22(5): 282-290. doi: 10.1111/1751-2980.12986

Jiang JX, Liu Q, Zhao B, et al. Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28, 745 cases[J]. J Cancer Res Clin Oncol, 2017, 143(3): 409-418. doi: 10.1007/s00432-016-2299-9

Tang XD, Zhou LY, Zhang ST, et al. Randomized double-blind clinical trial of Moluodan for the treatment of chronic atrophic gastritis with dysplasia[J]. Chin J Integr Med, 2016, 22(1): 9-18. doi: 10.1007/s11655-015-2114-5

Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial[J]. JAMA, 2004, 291(2): 187-194. doi: 10.1001/jama.291.2.187

Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality[J]. J Natl Cancer Inst, 2012, 104(6): 488-492. doi: 10.1093/jnci/djs003

Doorakkers E, Lagergren J, Engstrand L, et al. Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population[J]. Gut, 2018, 67(12): 2092-2096. doi: 10.1136/gutjnl-2017-315363

Leung WK, Wong I, Cheung KS, et al. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals[J]. Gastroenterology, 2018, 155(1): 67-75. doi: 10.1053/j.gastro.2018.03.028

Ford AC, Forman D, Hunt RH, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials[J]. BMJ, 2014, 348: g3174. doi: 10.1136/bmj.g3174

Choi IJ, Kim CG, Lee JY, et al. Family History of Gastric Cancer and Helicobacter pylori Treatment[J]. N Engl J Med, 2020, 382(5): 427-436. doi: 10.1056/NEJMoa1909666

Chen HN, Wang Z, Li X, et al. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis[J]. Gastric Cancer, 2016, 19(1): 166-175. doi: 10.1007/s10120-015-0462-7

Li WQ, Ma JL, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups[J]. J Natl Cancer Inst, 2014, 106(7): dju116.

den Hollander WJ, Holster IL, den Hoed CM, et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions[J]. Gut, 2019, 68(4): 585-593. doi: 10.1136/gutjnl-2017-314498

Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer[J]. Cancer Epidemiol Biomarkers Prev, 1997, 6(8): 639-642.

Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial[J]. Lancet, 2008, 372(9636): 392-397. doi: 10.1016/S0140-6736(08)61159-9

Choi J, Kim SG, Yoon H, et al. Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma[J]. Clin Gastroenterol Hepatol, 2014, 12(5): 793-800. doi: 10.1016/j.cgh.2013.09.057

Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer[J]. N Engl J Med, 2018, 378(12): 1085-1095. doi: 10.1056/NEJMoa1708423

成虹, 胡伏莲, 盛剑秋, 等. 荆花胃康胶丸联合含呋喃唑酮三联或四联疗法补救治疗幽门螺杆菌感染的多中心随机对照研究[J]. 中华医学杂志, 2016, 96(40): 3206-3212. doi: 10.3760/cma.j.issn.0376-2491.2016.40.002

李建勋, 吕宾, 杜勤, 等. 荆花胃康胶丸联合铋剂四联治疗幽门螺杆菌阳性慢性胃炎多中心随机对照研究[J]. 中国中西医结合消化杂志, 2018, 26(12): 998-1004. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201812007.htm

何孝明, 黄宣. 胃复春联合四联疗法治疗H. pylori相关性慢性非萎缩性胃炎临床疗效观察[J]. 世界华人消化杂志, 2017, 25(6): 521-525. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201706008.htm

Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies[J]. Nutr Cancer, 2005, 53(1): 1-10. doi: 10.1207/s15327914nc5301_1

Kong P, Cai Q, Geng Q, et al. Vitamin intake reduce the risk of gastric cancer: meta-analysis and systematic review of randomized and observational studies[J]. PLoS One, 2014, 9(12): e116060. doi: 10.1371/journal.pone.0116060

Dawsey SP, Hollenbeck A, Schatzkin A, et al. A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers[J]. PLoS One, 2014, 9(2): e88774. doi: 10.1371/journal.pone.0088774

Li WQ, Zhang JY, Ma JL, et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial[J]. BMJ, 2019, 366: l5016.

朱舜时, Joel Mason, 施尧, 等. 叶酸对胃癌和其他胃肠道癌发生的干预作用——临床试验七年随访[J]. 胃肠病学, 2002, 7(2): 73-78. doi: 10.3969/j.issn.1008-7125.2002.02.003

Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy[J]. J Natl Cancer Inst, 2000, 92(23): 1881-1888. doi: 10.1093/jnci/92.23.1881

You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions[J]. J Natl Cancer Inst, 2006, 98(14): 974-983. doi: 10.1093/jnci/djj264

Plummer M, Vivas J, Lopez G, et al. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population[J]. J Natl Cancer Inst, 2007, 99(2): 137-146. doi: 10.1093/jnci/djk017

Taylor PR. Prevention of gastric cancer: a miss[J]. J Natl Cancer Inst, 2007, 99(2): 101-103. doi: 10.1093/jnci/djk026

吴玉秋, 刘洪明, 柴霞. 叶酸联合幽门螺杆菌根除治疗慢性萎缩性胃炎患者疾病进展和黏膜转归的影响因素分析[J]. 江苏医药, 2018, 44(11): 1283-1286. https://www.cnki.com.cn/Article/CJFDTOTAL-YIYA201811016.htm

戴源泉, 叶正登, 黄欢欢. 幽门螺杆菌根除疗法结合叶酸对慢性萎缩性胃炎患者的远期效果[J]. 世界华人消化杂志, 2017, 25(19): 1777-1782. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201719017.htm

魏霞, 钦丹萍. 中医药治疗慢性萎缩性胃炎伴异型增生疗效的系统评价[J]. 浙江中医药大学学报, 2013, 37(7): 864-869. doi: 10.3969/j.issn.1005-5509.2013.07.012

李芳, 韩吉. 中药治疗胃上皮异型增生疗效的Meta分析[J]. 中医药导报, 2017, 23(14): 108-112. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201714037.htm

杨湘怡, 吴云林, 朱燕华, 等. 胃黏膜低级别上皮内瘤变的胃复春联用叶酸治疗及转归研究[J]. 内科理论与实践, 2013, 8(1): 24-28. https://www.cnki.com.cn/Article/CJFDTOTAL-NKLL201301012.htm

曹艳菊, 屈昌民, 吴继华, 等. 叶酸联合胃复春治疗萎缩性胃炎癌前病变的疗效[J]. 世界华人消化杂志, 2013, 21(30): 3261-3264. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201330024.htm

冯瑞兵. 摩罗丹联合叶酸治疗慢性萎缩性胃炎伴异型增生的临床研究[J]. 河北中医, 2011, 33(6): 865-867. doi: 10.3969/j.issn.1002-2619.2011.06.038

钟国新, 李素荷. 基于CONSORT和STRICTA评价针灸治疗慢性萎缩性胃炎临床随机对照试验报告的质量[J]. 时珍国医国药, 2013, 24(4): 983-986. doi: 10.3969/j.issn.1008-0805.2013.04.101

李敬华, 封毅, 罗良涛. 慢性胃炎中医药研究文献的数据分析及质量评价研究[J]. 世界中医药, 2013, 8(12): 1490-1492, 1495-1495. doi: 10.3969/j.issn.1673-7202.2013.12.035

刘珊, 苏泽琦, 刘逍遥, 等. 基于PubMed和Web of Science数据库对中医药治疗慢性萎缩性胃炎现状的文献分析[J]. 中国实验方剂学杂志, 2021, 27(6): 149-158. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202106020.htm

Schulz KF, Altman DG, Moher D. the CONSORT Group. CONSORT 2010声明: 报告平行对照随机临床试验指南的更新[J]. 中西医结合学报, 2010, 8(7): 604-612.

王萍, 张北华, 王凤云, 等. 胃癌前病变的疗效评价研究[J], 医学与哲学. 2015, 36(539): 18-20. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZL201512006.htm

李媛. 胃黏膜不典型增生性肠化及异型增生: 形态学及分子生物学研究[D]. 北京: 北京协和医院, 2012.